Medical Industry Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Medical Industry Today.

Press releases published on August 6, 2026

Aug. 6, 2026

SIGA Reports Financial Results for Three and Six Months Ended June 30, 2026

Indeterminate GlobeNewswire

Aug. 6, 2026

Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 6, 2026

Tectonic Therapeutic Announces Second Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire

Aug. 6, 2026

Senseonics Holdings, Inc. Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 6, 2026

Denali Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights

Indeterminate GlobeNewswire

Aug. 6, 2026

Ascendis to Report Second Quarter 2026 Financial Results and Provide Business Update on August 13, 2026

Indeterminate GlobeNewswire

Aug. 6, 2026

Dentsply Sirona Reports Second Quarter 2026 Results

Indeterminate GlobeNewswire

Aug. 6, 2026

Verrica Pharmaceuticals Closes Credit Facility For Up To $27.5 Million in Non-Dilutive Growth Capital 

Indeterminate GlobeNewswire

Aug. 6, 2026

NextCure Provides Business Update and Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 6, 2026

Xenon Reports Q2 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Aug. 6, 2026

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 6, 2026

Progyny, Inc. Announces Second Quarter 2026 Results

Indeterminate GlobeNewswire

Aug. 6, 2026

Cytokinetics Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Aug. 6, 2026

INmune Bio Inc. Announces Second Quarter 2026 Results and Highlights Regulatory, Manufacturing and Clinical Progress

Indeterminate GlobeNewswire

Aug. 6, 2026

Replimune Announces FDA Accelerated Approval of TUDRIQEVTM in Combination with Nivolumab for Unresectable Advanced Cutaneous Melanoma After Progression on an anti-PD-1 Based Regimen

Indeterminate GlobeNewswire

Aug. 6, 2026

enGenome and Genetic Alliance Partner to Expand Access to Advanced Genomic Interpretation for Rare Disease

Indeterminate EIN Presswire

Aug. 6, 2026

JelriSoFit Introduces a Women’s Three-Piece Scrub Set for the Realities of the Healthcare Workweek

Indeterminate EIN Presswire

Aug. 6, 2026

Beyond Key Among Select Microsoft Partners Recognized for Microsoft Fabric Expertise

Indeterminate EIN Presswire

Aug. 6, 2026

Top Therapeutic And Pharmaceutical Peptides Manufacturer Expands Innovation in Global Peptide Solutions

Indeterminate EIN Presswire

Aug. 6, 2026

Five Reputable Custom Packaging Solutions Providers in Asia 2026: Advancing Bespoke Plastic Packaging Manufacturing

Indeterminate EIN Presswire